These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 22066971)

  • 1. The type I interferon system in the etiopathogenesis of autoimmune diseases.
    Rönnblom L
    Ups J Med Sci; 2011 Nov; 116(4):227-37. PubMed ID: 22066971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of IFNα in adult lupus.
    Rönnblom L
    Arthritis Res Ther; 2010; 12 Suppl 1(Suppl 1):S3. PubMed ID: 20392290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The important roles of type I interferon and interferon-inducible genes in systemic lupus erythematosus.
    Luo S; Wang Y; Zhao M; Lu Q
    Int Immunopharmacol; 2016 Nov; 40():542-549. PubMed ID: 27769023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-α production by plasmacytoid dendritic cell associations with polymorphisms in gene loci related to autoimmune and inflammatory diseases.
    Berggren O; Alexsson A; Morris DL; Tandre K; Weber G; Vyse TJ; Syvänen AC; Rönnblom L; Eloranta ML
    Hum Mol Genet; 2015 Jun; 24(12):3571-81. PubMed ID: 25779693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic lupus erythematosus and the type I interferon system.
    Rönnblom L; Alm GV
    Arthritis Res Ther; 2003; 5(2):68-75. PubMed ID: 12718746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.
    Mavragani CP; Sagalovskiy I; Guo Q; Nezos A; Kapsogeorgou EK; Lu P; Liang Zhou J; Kirou KA; Seshan SV; Moutsopoulos HM; Crow MK
    Arthritis Rheumatol; 2016 Nov; 68(11):2686-2696. PubMed ID: 27338297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cause and consequences of the activated type I interferon system in SLE.
    Eloranta ML; Rönnblom L
    J Mol Med (Berl); 2016 Oct; 94(10):1103-1110. PubMed ID: 27094810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An etiopathogenic role for the type I IFN system in SLE.
    Rönnblom L; Alm GV
    Trends Immunol; 2001 Aug; 22(8):427-31. PubMed ID: 11473831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitor of IkappaB kinase activity, BAY 11-7082, interferes with interferon regulatory factor 7 nuclear translocation and type I interferon production by plasmacytoid dendritic cells.
    Miyamoto R; Ito T; Nomura S; Amakawa R; Amuro H; Katashiba Y; Ogata M; Murakami N; Shimamoto K; Yamazaki C; Hoshino K; Kaisho T; Fukuhara S
    Arthritis Res Ther; 2010; 12(3):R87. PubMed ID: 20470398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgE Inhibits Toll-like Receptor 7- and Toll-like Receptor 9-Mediated Expression of Interferon-α by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
    Khoryati L; Augusto JF; Shipley E; Contin-Bordes C; Douchet I; Mitrovic S; Truchetet ME; Lazaro E; Duffau P; Couzi L; Jacquemin C; Barnetche T; Vacher P; Schaeverbeke T; Blanco P; Richez C;
    Arthritis Rheumatol; 2016 Sep; 68(9):2221-31. PubMed ID: 26991804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous type I interferon inducers in autoimmune diseases.
    Finke D; Eloranta ML; Rönnblom L
    Autoimmunity; 2009 May; 42(4):349-52. PubMed ID: 19811298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormalities of the type I interferon signaling pathway in lupus autoimmunity.
    Gallucci S; Meka S; Gamero AM
    Cytokine; 2021 Oct; 146():155633. PubMed ID: 34340046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus.
    Cham CM; Ko K; Niewold TB
    Clin Dev Immunol; 2012; 2012():780436. PubMed ID: 23251221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein inhibits plasmacytoid dendritic cell interferon responses to autoantibody immune complexes.
    Mold C; Clos TW
    Arthritis Rheum; 2013 Jul; 65(7):1891-901. PubMed ID: 23576062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-interferon alpha treatment in SLE.
    Kirou KA; Gkrouzman E
    Clin Immunol; 2013 Sep; 148(3):303-12. PubMed ID: 23566912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational state of C-reactive protein is critical for reducing immune complex-triggered type I interferon response: Implications for pathogenic mechanisms in autoimmune diseases imprinted by type I interferon gene dysregulation.
    Svanberg C; Enocsson H; Govender M; Martinsson K; Potempa LA; Rajab IM; Fernandez-Botran R; Wetterö J; Larsson M; Sjöwall C
    J Autoimmun; 2023 Feb; 135():102998. PubMed ID: 36706536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-α production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes is promoted by NK cells via MIP-1β and LFA-1.
    Hagberg N; Berggren O; Leonard D; Weber G; Bryceson YT; Alm GV; Eloranta ML; Rönnblom L
    J Immunol; 2011 May; 186(9):5085-94. PubMed ID: 21430220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunctional interferon-alpha production by peripheral plasmacytoid dendritic cells upon Toll-like receptor-9 stimulation in patients with systemic lupus erythematosus.
    Kwok SK; Lee JY; Park SH; Cho ML; Min SY; Park SH; Kim HY; Cho YG
    Arthritis Res Ther; 2008; 10(2):R29. PubMed ID: 18321389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of type I interferon in systemic autoimmune diseases.
    Crow MK; Olferiev M; Kirou KA
    Transl Res; 2015 Feb; 165(2):296-305. PubMed ID: 25468480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of the type I interferon system in autoimmunity.
    Rönnblom L
    Clin Exp Rheumatol; 2016; 34(4 Suppl 98):21-4. PubMed ID: 27586799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.